Back to search

Article

Genetic Events Inhibiting Apoptosis in Diffuse Large B-cell Lymphoma

2021-04-14

Abstract excerpt

Diffuse large B cell lymphoma (DLBCL) is curable with chemoimmunotherapy in ~65% of patients. One of the hallmarks of the pathogenesis and resistance to therapy in DLBCL is inhibition of apoptosis, which allows malignant cells to survive and acquire further alterations. Inhibition of apoptosis can be the result of genetic events inhibiting the intrinsic or extrinsic apoptotic pathways, as well as their modulators,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b097cb17-2178-5e54-b059-7b93aa2da486
DOI
10.20944/preprints202104.0376.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic Events Inhibiting Apoptosis in Diffuse Large B-cell LymphomaDOI 10.20944/preprints202104.0376.v1
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell LymphomaSemantic proximity
Altered pathways and targeted therapy in double hit lymphomaSemantic proximity
Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma.Semantic proximity
Molecular pathogenesis of diffuse large B-cell lymphoma.Semantic proximity
Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review).Semantic proximity
Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy ResistanceSemantic proximity
Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment.Semantic proximity
Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic ImplicationsSemantic proximity
Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphomaSemantic proximity
Diffuse large B cell lymphoma: molecular targeted therapy.Semantic proximity
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approachSemantic proximity
Genetic lesions in diffuse large B-cell lymphomas.Semantic proximity
Select a neighboring publication to make it the new centre.